ArticleMolecular cancer research : MCR2018

ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.

Avital Lev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.